U.S. Senate to Continue Consideration of 21st Century Cures Wednesday

By a vote of 85 to 13, the U.S. Senate on Monday invoked cloture for H.R. 34, the 21st Century Cures Act. The Senate resumed post-cloture consideration of the bill on Tuesday and and will now resume on Wednesday, with a vote likely at 2 pm.

U.S. House of Representative Energy and Commerce Committee Chairman Fred Upton (R-MI) and Rep. Diana DeGette (D-CO), sponsors of the 21st Century Cures Act, issued the following statement following the Senate’s cloture vote: "With today’s resounding vote, we’re excited the decks have been cleared for 21st Century Cures,” Upton and DeGette said. “This effort represents the very best of Congress, coming together and working toward a greater cause, a cause for hope. We were particularly delighted to share in the moment with Vice President Biden, NIH’s Dr. Collins, and Ellen Sigal. This is a big deal. After three years on the #Path2Cures, there’s a light at the end of the tunnel, and it’s called the White House. We can say with certainty - #CuresNow, it’s going to happen.”